Target
Cannabinoid receptor 2
Ligand
BDBM260131
Substrate
n/a
Meas. Tech.
cAMP Assay
Temperature
310.15±n/a K
EC50
74.7±n/a nM
Comments
extracted
Citation
 Frei, BGobbi, LGrether, UKimbara, ANettekoven, MRoever, SRogers-Evans, MSchulz-Gasch, T Pyridine derivatives US Patent  US9522886 Publication Date 12/20/2016 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM260131
Synonyms:
US9522886, 79
Type:
Small organic molecule
Emp. Form.:
C17H15ClFN3O4S
Mol. Mass.:
411.835
SMILES:
NC(=O)CC1(CS(=O)(=O)C1)NC(=O)c1cccc(n1)-c1ccc(F)c(Cl)c1
Structure:
Search PDB for entries with ligand similarity: